Literature DB >> 15565747

Toremifene citrate (Fareston).

Patty Gerken1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15565747     DOI： 10.1188/04.CJON.529-530

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN： 1092-1095            Impact factor:   1.027


× No keyword cloud information.
  2 in total

1.  Toremifene-atamestane; alone or in combination: predictions from the preclinical intratumoral aromatase model.

Authors:  Gauri J Sabnis; Luciana Macedo; Olga Goloubeva; Adam Schayowitz; Yue Zhu; Angela Brodie
Journal:  J Steroid Biochem Mol Biol       Date:  2007-09-07       Impact factor: 4.292

2.  Testing therapeutics in cell-based assays: Factors that influence the apparent potency of drugs.

Authors:  Elena Postnikova; Yu Cong; Lisa Evans DeWald; Julie Dyall; Shuiqing Yu; Brit J Hart; Huanying Zhou; Robin Gross; James Logue; Yingyun Cai; Nicole Deiuliis; Julia Michelotti; Anna N Honko; Richard S Bennett; Michael R Holbrook; Gene G Olinger; Lisa E Hensley; Peter B Jahrling
Journal:  PLoS One       Date:  2018-03-22       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.